申请人:Cell Therapeutics, Inc.
公开号:US20030153570A1
公开(公告)日:2003-08-14
The invention relates to aryl triazines and uses thereof, including to inhibit lysophosphatidic acid acyltransferase &bgr; (LPAAT-&bgr;) activity and/or proliferation of cells such as tumor cells.
本发明涉及芳基三嗪及其用途,包括用于抑制溶血磷脂酸酰基转移酶β(LPAAT-β)活性和/或诸如肿瘤细胞的细胞增殖。